PCN71 COST-EFFECTIVENESS OF ORALTOPOTECAN PLUS BEST SUPPORTIVE CARE VERSUS BEST SUPPORTIVE CARE ALONE IN PATIENTS WITH RELAPSED SMALL-CELL LUNG CANCER (SCLC) IN THE UK
Nov 1, 2008, 00:00
10.1016/S1098-3015(10)66607-7
https://www.valueinhealthjournal.com/article/S1098-3015(10)66607-7/fulltext
Title :
PCN71 COST-EFFECTIVENESS OF ORALTOPOTECAN PLUS BEST SUPPORTIVE CARE VERSUS BEST SUPPORTIVE CARE ALONE IN PATIENTS WITH RELAPSED SMALL-CELL LUNG CANCER (SCLC) IN THE UK
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66607-7&doi=10.1016/S1098-3015(10)66607-7
First page :
Section Title :
Open access? :
No
Section Order :
444